RFA-NS-23-004: Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $400,000 to state and local governments and tribes. Applications closed on September 2, 2022.
From the official notice on Grants.gov, last changed July 22, 2022. Checked November 7, 2026.
- Award ceiling$400,000
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU01
- Clinical trialsNot allowed
- Funded byNINDS
- Median yearly award$608,306
- Typical project length7.5 years
- U01, Research Project Cooperative Agreement. Like an R01, but NIH staff are substantially involved in the work. Other open U01 notices.
Projects funded under RFA-NS-23-004 were run by National Institute of Neurological Disorders and Stroke (NINDS, 11 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-NS-23-004 in the NIH Guide.
Key dates
| Posted | July 22, 2022 |
|---|---|
| Deadline | September 2, 2022 |
| Archived by Grants.gov | October 8, 2022 |
Who can apply
This opportunity was open to state and local governments and tribes.
- Independent school districts
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $608,306; it allows up to $400,000 per award.
- Most of the money in the 2 programs behind this notice (75% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this Limited Competition Funding Opportunity Announcement is to allow Undiagnosed Diseases Network (UDN) Clinical Sites that received an NIH award under RFA-RM-17-019 an opportunity to compete for one additional year of NIH funding to: continue their participation in the UDN; establish collaborations and efficient processes with the next phase Data Management and Coordinating Center (DMCC; see: RFA-NS-22-051); enroll and evaluate new participants; and further develop their sustainability plans.
Funded under RFA-NS-23-004 so far
NIH funded 11 projects under RFA-NS-23-004 in fiscal 2023, at 11 institutions. The median yearly award was $608,306.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| An integrated and diverse genomic medicine program for undiagnosed diseases | Duke University | 2023 | $599,268 |
| Pacific Northwest Undiagnosed Diseases Network Clinical Site | University of Washington | 2023 | $470,641 |
| BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase III (U01) | Baylor College of Medicine | 2023 | $628,000 |
| UDN@CHOP/UPENN: transition to sustainability | Children's Hosp of Philadelphia | 2023 | $356,000 |
| Center for Undiagnosed Diseases at Stanford | Stanford University | 2023 | $596,270 |
| UCLA clinical site for the investigation of undiagnosed disorders | University of California Los Angeles | 2023 | $623,949 |
| Center for Integrated Approaches to Undiagnosed Diseases | Brigham and Women's Hospital | 2023 | $518,031 |
| Intermountain West Clinical Site for the Undiagnosed Disease Network (UDN) Continuation | Utah State Higher Education System--University of Utah | 2023 | $615,667 |
Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before
From fiscal 2021 to 2025, Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $9.1 billion across 8,641 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 203 | $288 million |
| The Regents of the University of California, San Francisco | California | 248 | $277 million |
| The Johns Hopkins University | Maryland | 230 | $276 million |
| The Trustees of Columbia University in the City of New York | New York | 188 | $226 million |
| Regents of the University of Michigan | Michigan | 179 | $221 million |
Who has won Human Genome Research grants before
From fiscal 2021 to 2025, Human Genome Research (93.172) awarded $2.2 billion across 1,255 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Leland Stanford Junior University | California | 59 | $153 million |
| University of Washington | Washington | 46 | $123 million |
| The Broad Institute, Inc | Massachusetts | 22 | $119 million |
| University of California Santa Cruz | California | 17 | $64.7 million |
| Baylor College of Medicine | Texas | 24 | $62.9 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-NS-23-004 still open?
No. It closed on September 2, 2022.
Who can apply for Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)?
Closed September 2, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $400,000 each.
Who has been funded under RFA-NS-23-004?
NIH RePORTER lists 11 projects funded under RFA-NS-23-004 in fiscal 2023, at 11 institutions. The most were at Duke University, University of Washington, Baylor College of Medicine.
Who has won Human Genome Research grants before?
The largest recipients over five fiscal years were The Leland Stanford Junior University, University of Washington, The Broad Institute, Inc. The program made 1,255 awards worth $2.2 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
- Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)